Convenient Embryonic Stem-Cell Expansion

Courtesy of Jong-Hoon Kim & Ron McKay, NIHA human embryonic stem cell starter panel that allows for the in vitro expansion of human ESCs is now available from Minneapolis-based R&D Systems http://www.rndsystems.com. The kit contains human FGF basic protein, antibodies to Oct-3/4, stage-specific embryonic antigen (SSEA)-4, and alkaline phosphatase to monitor the cells' differentiation status."The biggest plus as well as the biggest problem with ESCs is that they are multipotential and can

Written byEmma Hitt
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of Jong-Hoon Kim & Ron McKay, NIH

A human embryonic stem cell starter panel that allows for the in vitro expansion of human ESCs is now available from Minneapolis-based R&D Systems http://www.rndsystems.com. The kit contains human FGF basic protein, antibodies to Oct-3/4, stage-specific embryonic antigen (SSEA)-4, and alkaline phosphatase to monitor the cells' differentiation status.

"The biggest plus as well as the biggest problem with ESCs is that they are multipotential and can differentiate into a bewildering variety of cells," says Mahendra Rao, section chief of the Stem Cell Biology Unit, Laboratory of Neurosciences, National Institute on Aging. According to Rao, the antibodies included in the kit will provide a simple, reliable way to profile the state of the cells. He adds, "Markers of this type that are quality tested on human cells have not been available, and I believe that such reagents will be very popular."

- Emma ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies